Contineum Therapeutics, Inc. Class A Common Stock (CTNM) — Free Cash Flow Generation Index
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a Free Cash Flow Generation Index of 1.00x as of June 2023. Free cash flow of $40.64 Million represents 1% of operating cash flow ($40.67 Million). Read CTNM liabilities breakdown for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Contineum Therapeutics, Inc. Class A Common Stock Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Contineum Therapeutics, Inc. Class A Common Stock across 1 annual periods. Explore CTNM capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Contineum Therapeutics, Inc. Class A Common Stock (2023–2023)
Year-by-year Free Cash Flow Generation Index for Contineum Therapeutics, Inc. Class A Common Stock. For the full company profile including market capitalisation, see Contineum Therapeutics, Inc. Class A Com market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.98x | $18.93 Million | $19.35 Million | $414.00K | — |